Omega-3 Fatty Acids Prevent Early Pancreatic Carcinogenesis via Repression of the AKT Pathway
- PMID: 30213082
- PMCID: PMC6163264
- DOI: 10.3390/nu10091289
Omega-3 Fatty Acids Prevent Early Pancreatic Carcinogenesis via Repression of the AKT Pathway
Abstract
Pancreatic cancer remains a daunting foe despite a vast number of accumulating molecular analyses regarding the mutation and expression status of a variety of genes. Indeed, most pancreatic cancer cases uniformly present with a mutation in the KRAS allele leading to enhanced RAS activation. Yet our understanding of the many epigenetic/environmental factors contributing to disease incidence and progression is waning. Epidemiologic data suggest that diet may be a key factor in pancreatic cancer development and potentially a means of chemoprevention at earlier stages. While diets high in ω3 fatty acids are typically associated with tumor suppression, diets high in ω6 fatty acids have been linked to increased tumor development. Thus, to better understand the contribution of these polyunsaturated fatty acids to pancreatic carcinogenesis, we modeled early stage disease by targeting mutant KRAS to the exocrine pancreas and administered diets rich in these fatty acids to assess tumor formation and altered cell-signaling pathways. We discovered that, consistent with previous reports, the ω3-enriched diet led to reduced lesion penetrance via repression of proliferation associated with reduced phosphorylated AKT (pAKT), whereas the ω6-enriched diet accelerated tumor formation. These data provide a plausible mechanism underlying previously observed effects of fatty acids and suggest that administration of ω3 fatty acids can reduce the pro-survival, pro-growth functions of pAKT. Indeed, counseling subjects at risk to increase their intake of foods containing higher amounts of ω3 fatty acids could aid in the prevention of pancreatic cancer.
Keywords: chemoprevention; neoplastic disease; pancreatic cancer; polyunsaturated fatty acids; proliferation.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.Gastroenterology. 2014 Nov;147(5):1119-33.e4. doi: 10.1053/j.gastro.2014.08.002. Epub 2014 Aug 12. Gastroenterology. 2014. PMID: 25127677
-
NFATc1 Links EGFR Signaling to Induction of Sox9 Transcription and Acinar-Ductal Transdifferentiation in the Pancreas.Gastroenterology. 2015 May;148(5):1024-1034.e9. doi: 10.1053/j.gastro.2015.01.033. Epub 2015 Jan 23. Gastroenterology. 2015. PMID: 25623042 Free PMC article.
-
Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16.Gastroenterology. 2015 Jun;148(7):1452-65. doi: 10.1053/j.gastro.2015.02.009. Epub 2015 Feb 13. Gastroenterology. 2015. PMID: 25683115
-
Critical role of oncogenic KRAS in pancreatic cancer (Review).Mol Med Rep. 2016 Jun;13(6):4943-9. doi: 10.3892/mmr.2016.5196. Epub 2016 Apr 27. Mol Med Rep. 2016. PMID: 27121414 Review.
-
Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realities.Eur J Cancer. 2016 Feb;54:75-83. doi: 10.1016/j.ejca.2015.11.012. Epub 2015 Dec 28. Eur J Cancer. 2016. PMID: 26735353 Review.
Cited by
-
Mechanisms of obesity- and diabetes mellitus-related pancreatic carcinogenesis: a comprehensive and systematic review.Signal Transduct Target Ther. 2023 Mar 24;8(1):139. doi: 10.1038/s41392-023-01376-w. Signal Transduct Target Ther. 2023. PMID: 36964133 Free PMC article.
-
Palmitoylation-driven PHF2 ubiquitination remodels lipid metabolism through the SREBP1c axis in hepatocellular carcinoma.Nat Commun. 2023 Oct 12;14(1):6370. doi: 10.1038/s41467-023-42170-0. Nat Commun. 2023. PMID: 37828054 Free PMC article.
-
Krill oil extract inhibits the migration of human colorectal cancer cells and down-regulates EGFR signalling and PD-L1 expression.BMC Complement Med Ther. 2020 Dec 7;20(1):372. doi: 10.1186/s12906-020-03160-7. BMC Complement Med Ther. 2020. PMID: 33287803 Free PMC article.
-
The role of metabolic reprogramming in pancreatic cancer chemoresistance.Front Pharmacol. 2023 Jan 9;13:1108776. doi: 10.3389/fphar.2022.1108776. eCollection 2022. Front Pharmacol. 2023. PMID: 36699061 Free PMC article. Review.
-
Mitophagy-mediated molecular subtypes depict the hallmarks of the tumour metabolism and guide precision chemotherapy in pancreatic adenocarcinoma.Front Cell Dev Biol. 2022 Jul 22;10:901207. doi: 10.3389/fcell.2022.901207. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35938160 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous